Answers are grounded in this paper and cite their sources.
The International Working Group for the Harmonization of Dementia Drug Guidelines has been active for more than 5 years attempting to improve the efficiency of international drug development. A virtual organization was formed of clinicians, scientists, industries, participants, and regulators from various nations around the world. This article summarizes a variety of conferences and physicians' papers focusing on aspects of trials ranging from diagnosis, assessment, and trial design to pharmacoeconomics and ethics.
No takes yet. Share an insight, caveat, or question.
Peter J. Whitehouse (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: